Original language | English |
---|---|
Number of pages | 2 |
Journal | Journal of Clinical Oncology |
Volume | 34 |
Issue number | 15 |
DOIs | |
Publication status | Published - 20-May-2016 |
Event | Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 2-Jun-2017 → 6-Jun-2017 |
A Phase 1 study of RAD1901, an oral selective estrogen receptor degrader, in ER positive, HER2 negative, advanced breast cancer patients.
Elisabeth G. E. de Vries, Clasina Marieke Venema, Andor W. J. M. Glaudemans, Lorraine Fitzpatrick, Dinesh Purandare, Gary Hattersley, Fiona Garner
Research output: Contribution to journal › Meeting Abstract › Academic